As of January 23, 2025, Nfl Biosciences SAS (ALNFL.PA) has a market cap of $18.739 million USD. According to our data, Nfl Biosciences SAS is ranked No.8634 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $18.74 M |
-4.97%
|
Dec 31, 2024 | $19.72 M |
36.81%
|
Dec 29, 2023 | $14.41 M |
-26.72%
|
Dec 30, 2022 | $19.67 M |
-18.13%
|
Dec 31, 2021 | $24.02 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Jazz Pharmaceuticals
JAZZ
|
$7.31 B |
0.000 M
|
Ireland
|
Corbus Pharmaceuticals
CRBP
|
$0.14 B |
-0.000 M
|
USA
|
Cara Therapeutics
CARA
|
$21.85 M |
0.000 M
|
USA
|
Tilray
TLRY
|
$1.06 B |
0.000 M
|
Canada
|
Aurora Cannabis
ACB
|
$0.21 B |
-0.000 M
|
Canada
|
Canopy Growth
CGC
|
$0.33 B |
58.562 M
|
Canada
|
Cronos Group
CRON
|
$0.73 B |
0.000 M
|
Canada
|
OrganiGram Holdings
OGI
|
$0.20 B |
0.631 M
|
Canada
|
Market Cap | = | ALNFL.PA Stock Price | * | ALNFL.PA Shares Outstanding |
= | $1.95 | * | 9.61 M | |
= | $18.74 M |